Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-01-03 @ 3:09 PM
Study NCT ID:
NCT00929058
Status:
COMPLETED
Last Update Posted:
2010-05-18
First Post:
2009-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab and Vasoconstriction
Sponsor:
Radboud University Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BVZ1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Paul Smits
Old Organization:
UMCN